PRESS DIGEST- Financial Times - July 7

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines

- Twitter threatens trade secrets lawsuit over Meta's Threads app https://on.ft.com/44xxGtp - US regulators approve first drug to slow progression of Alzheimer's https://on.ft.com/46xnuDj

- FIS sells majority stake in Worldpay to buyout group at $18.5 bln valuation https://on.ft.com/44xmw83 - RMT announce fresh strikes on London Underground in late July https://on.ft.com/44pBxsC

Overview - Elon Musk-owned Twitter on Thursday threatened to sue Meta Platforms over its new Threads platform, which attracted more than 30 million sign ups after it was launched on Wednesday.

- The U.S. Food and Drug Administration said on Thursday it granted full approval for the first Alzheimer's drug Leqembi, which is developed by Eisai and Biogen. - Private equity firm GTCR has agreed to buy a majority stake in Worldpay, the merchant payments unit of Fidelity National Information Services, in a deal that values the unit at $18.5 billion.

- UK's trade union RMT said on Thursday that London underground rail staff will go on a five-day strike from July 23-28 over pensions and working conditions. (Compiled by Bengaluru newsroom)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)